Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Commentary

Controversies in the diagnosis and management of testosterone deficiency syndrome

Geoffrey I. Hackett
CMAJ December 08, 2015 187 (18) 1342-1344; DOI: https://doi.org/10.1503/cmaj.151208
Geoffrey I. Hackett
Heartlands Hospital, Birmingham, UK
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Responses
  • Metrics
  • PDF
Loading
Submit a Response to This Article
Compose Response

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
References
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'. Minimum 7 characters.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'. Minimum 12 characters.
Your organization, institution's or residential address.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

  • Statin and hypogonadism
    Dhastagir S Sheriff
    Posted on: 22 December 2015
  • Posted on: (22 December 2015)
    Page navigation anchor for Statin and hypogonadism
    Statin and hypogonadism
    • Dhastagir S Sheriff, Professor

    Hypogonadism in men is one of the conditions that needs therapeutic attention and intervention. It is reported to be associated with aging, diabetes and statin therapy. Obesity, diabetes and statin therapy are common in Libyan subjects. There are few studies undertaken to study the prevalence, association with diabetes and statin therapy in Libyan subjects. Libyan subjects who attended the Medicine Department, Faculty of...

    Show More

    Hypogonadism in men is one of the conditions that needs therapeutic attention and intervention. It is reported to be associated with aging, diabetes and statin therapy. Obesity, diabetes and statin therapy are common in Libyan subjects. There are few studies undertaken to study the prevalence, association with diabetes and statin therapy in Libyan subjects. Libyan subjects who attended the Medicine Department, Faculty of Medicine, Benghazi University, Libya from 2013-2014 were screened and 100 subjects were taken for the study. They were divided into: * in normal subjects undergoing statin therapy for dyslipidemia * in diabetes * in diabetes with statin therapy * in diabetic hypertensives * in diabetic hypertensives on statin therapy Subjects on statin therapy were grouped further into two categories - those who are undergoing statin therapy less than one year and those more than one year.

    **Hypogonadism was defined as low serum total testosterone (<300 ng/dL) and free (<5 ng/dL) testosterone in combination with low libido, ED, osteoporosis or fracture, or 2 or more of the following symptoms: sleep disturbance, depressed mood, lethargy, or diminished physical performance.

    In general serum testosterone levels are lowered in diabetes as well as in cases without diabetes on statin therapy. Reductions in serum testosterone levels were more prominent in patients with diabetics without hypertension on statin therapy. In patients with hypertension or hypertensive diabetics did not show marked reduction in serum testosterone levels though the effect is significant in diabetic hypertensives treated with statin for more than a year.

    One of the common casues of testosterone deficiency syndrome appears to be associated with statin therapy meant control and reduce serum cholesterol levels. Therefore, there needs to be a judicious combination of drugs prescribed for say hypercholesterolemia, particular in aging patients.

    Conflict of Interest:

    None declared

    Show Less
    Competing Interests: None declared.
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 187 (18)
CMAJ
Vol. 187, Issue 18
8 Dec 2015
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Controversies in the diagnosis and management of testosterone deficiency syndrome
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Controversies in the diagnosis and management of testosterone deficiency syndrome
Geoffrey I. Hackett
CMAJ Dec 2015, 187 (18) 1342-1344; DOI: 10.1503/cmaj.151208

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Controversies in the diagnosis and management of testosterone deficiency syndrome
Geoffrey I. Hackett
CMAJ Dec 2015, 187 (18) 1342-1344; DOI: 10.1503/cmaj.151208
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline
  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • How can Canada’s health systems improve care for people with chronic obstructive pulmonary disease?
  • Minimally invasive procedures in gender-affirming care: the case for public funding across Canada
  • Time for Canada to align with global innovations in treatment for tuberculosis
Show more Commentary

Similar Articles

Collections

  • Topics
    • Men's health
    • Sexual health

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire